Page last updated: 2024-11-05

tosufloxacin and Vomiting

tosufloxacin has been researched along with Vomiting in 1 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Atsumi, Y1
Yamanaka, H1
Shimozawa, K1
Yamanaka, J1
Uryu, H1
Mizukami, A1
Shichino, H1

Other Studies

1 other study available for tosufloxacin and Vomiting

ArticleYear
Drug-induced crystalluria attributable to tosufloxacin in children.
    Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1

    Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Crystalluria; Female; Fluoroquinolones;

2022